S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Bank Accounts: Frozen! (Ad)
Factory or farm? Oregon may alter land use for chipmakers
Travel disruption hits Germany on eve of transport strike
Bank Accounts: Frozen! (Ad)
Adele extends Las Vegas residency, plans concert film
Berlin climate proposal fails to get enough yes votes to win
Bank Accounts: Frozen! (Ad)
Turkmenistan votes for new, opposition-free parliament
Technical issues at Lufthansa cause delays in Frankfurt
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Bank Accounts: Frozen! (Ad)
Factory or farm? Oregon may alter land use for chipmakers
Travel disruption hits Germany on eve of transport strike
Bank Accounts: Frozen! (Ad)
Adele extends Las Vegas residency, plans concert film
Berlin climate proposal fails to get enough yes votes to win
Bank Accounts: Frozen! (Ad)
Turkmenistan votes for new, opposition-free parliament
Technical issues at Lufthansa cause delays in Frankfurt
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Bank Accounts: Frozen! (Ad)
Factory or farm? Oregon may alter land use for chipmakers
Travel disruption hits Germany on eve of transport strike
Bank Accounts: Frozen! (Ad)
Adele extends Las Vegas residency, plans concert film
Berlin climate proposal fails to get enough yes votes to win
Bank Accounts: Frozen! (Ad)
Turkmenistan votes for new, opposition-free parliament
Technical issues at Lufthansa cause delays in Frankfurt
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Bank Accounts: Frozen! (Ad)
Factory or farm? Oregon may alter land use for chipmakers
Travel disruption hits Germany on eve of transport strike
Bank Accounts: Frozen! (Ad)
Adele extends Las Vegas residency, plans concert film
Berlin climate proposal fails to get enough yes votes to win
Bank Accounts: Frozen! (Ad)
Turkmenistan votes for new, opposition-free parliament
Technical issues at Lufthansa cause delays in Frankfurt
TSE:HBP

Helix BioPharma - HBP Stock Forecast, Price & News

C$0.20
-0.02 (-9.30%)
(As of 03/22/2023)
Add
Compare
Today's Range
C$0.20
C$0.20
50-Day Range
C$0.19
C$0.23
52-Week Range
C$0.16
C$0.30
Volume
500 shs
Average Volume
5,358 shs
Market Capitalization
C$39.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

HBP stock logo

About Helix BioPharma (TSE:HBP) Stock

Helix BioPharma Corp. operates as an immune-oncology company in Canada. The company is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. It has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with University Hospital Tuebingen to assess the therapeutic response of L-DOS47 in cancer models expressing CEACAM6, with advanced preclinical metabolic imaging. The company is headquartered in Toronto, Canada.

Receive HBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Helix BioPharma and its competitors with MarketBeat's FREE daily newsletter.

HBP Stock News Headlines

Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
Helix BioPharma Corp.: Helix Announces Board Resignation
Stocks in play: Helix BioPharma Corp
See More Headlines
Receive HBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Helix BioPharma and its competitors with MarketBeat's FREE daily newsletter.

HBP Company Calendar

Today
3/26/2023
Next Earnings (Estimated)
6/13/2023

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Net Income
C$-5,520,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
C$0.02 per share
Book Value
C$0.01 per share

Miscellaneous

Free Float
N/A
Market Cap
C$40.00 million
Optionable
Optionable
Beta
-0.49

Key Executives

  • Mr. Jacek Antas
    CEO & Director
  • Mr. Hatem Kawar M.B.A. (Age 64)
    MBA, P.Eng, P.Eng., Chief Financial Officer
  • Dr. Gabrielle M. Siegers M.A.
    Ph.D., Head of R&D
  • Ms. Namrata Malhotra
    Corp. Sec.













HBP Stock - Frequently Asked Questions

How have HBP shares performed in 2023?

Helix BioPharma's stock was trading at C$0.22 at the start of the year. Since then, HBP shares have decreased by 7.0% and is now trading at C$0.20.
View the best growth stocks for 2023 here
.

When is Helix BioPharma's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 13th 2023.
View our HBP earnings forecast
.

What other stocks do shareholders of Helix BioPharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Helix BioPharma investors own include Lakeland Industries (LAKE), Liquidia (LQDA), Ovintiv (OVV), SIG (SHI), Green Organic Dutchman (TGOD), Zynerba Pharmaceuticals (ZYNE), American Airlines Group (AAL), Aurora Cannabis (ACB), Apollo Investment (AINV) and Aphria (APHA).

What is Helix BioPharma's stock symbol?

Helix BioPharma trades on the Toronto Stock Exchange (TSX) under the ticker symbol "HBP."

How do I buy shares of Helix BioPharma?

Shares of HBP stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Helix BioPharma's stock price today?

One share of HBP stock can currently be purchased for approximately C$0.20.

How much money does Helix BioPharma make?

Helix BioPharma (TSE:HBP) has a market capitalization of C$40.00 million. The biopharmaceutical company earns C$-5,520,000.00 in net income (profit) each year or C($0.04) on an earnings per share basis.

How can I contact Helix BioPharma?

Helix BioPharma's mailing address is 21 St Clair Ave E Suite 1100, TORONTO, ON M4T 1L9, Canada. The official website for the company is www.helixbiopharma.com. The biopharmaceutical company can be reached via phone at +1-416-9253232.

This page (TSE:HBP) was last updated on 3/27/2023 by MarketBeat.com Staff